Switch theme
Sign up to access all valuation multiples
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
1996
247
LTM Revenue $85.2M
LTM EBITDA $26.7M
$620M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Simulations Plus has a last 12-month revenue (LTM) of $85.2M and a last 12-month EBITDA of $26.7M.
In the most recent fiscal year, Simulations Plus achieved revenue of $70.0M and an EBITDA of $11.8M.
Simulations Plus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Simulations Plus valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $85.2M | XXX | $70.0M | XXX | XXX | XXX |
| Gross Profit | $52.0M | XXX | $43.2M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $26.7M | XXX | $11.8M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 17% | XXX | XXX | XXX |
| EBIT | $10.9M | XXX | $6.1M | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $11.0M | XXX | $10.0M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Simulations Plus's stock price is $32.
Simulations Plus has current market cap of $640M, and EV of $620M.
See Simulations Plus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $620M | $640M | XXX | XXX | XXX | XXX | $0.96 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Simulations Plus has market cap of $640M and EV of $620M.
Simulations Plus's trades at 8.1x EV/Revenue multiple, and 35.5x EV/EBITDA.
Equity research analysts estimate Simulations Plus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Simulations Plus has a P/E ratio of 58.4x.
See valuation multiples for Simulations Plus and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $640M | XXX | $640M | XXX | XXX | XXX |
| EV (current) | $620M | XXX | $620M | XXX | XXX | XXX |
| EV/Revenue | 7.3x | XXX | 8.1x | XXX | XXX | XXX |
| EV/EBITDA | 23.2x | XXX | 35.5x | XXX | XXX | XXX |
| EV/EBIT | 56.9x | XXX | 75.1x | XXX | XXX | XXX |
| EV/Gross Profit | 11.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 58.4x | XXX | 61.6x | XXX | XXX | XXX |
| EV/FCF | 64.6x | XXX | 42.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSimulations Plus's last 12 month revenue growth is 15%
Simulations Plus's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Simulations Plus's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Simulations Plus's rule of X is 70% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Simulations Plus and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 25% | XXX | 47% | XXX | XXX | XXX |
| Rule of 40 | 38% | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 70% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 53% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Simulations Plus acquired XXX companies to date.
Last acquisition by Simulations Plus was XXXXXXXX, XXXXX XXXXX XXXXXX . Simulations Plus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Simulations Plus founded? | Simulations Plus was founded in 1996. |
| Where is Simulations Plus headquartered? | Simulations Plus is headquartered in United States of America. |
| How many employees does Simulations Plus have? | As of today, Simulations Plus has 247 employees. |
| Who is the CEO of Simulations Plus? | Simulations Plus's CEO is Mr. Shawn O’Connor. |
| Is Simulations Plus publicy listed? | Yes, Simulations Plus is a public company listed on NAS. |
| What is the stock symbol of Simulations Plus? | Simulations Plus trades under SLP ticker. |
| When did Simulations Plus go public? | Simulations Plus went public in 1997. |
| Who are competitors of Simulations Plus? | Similar companies to Simulations Plus include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Simulations Plus? | Simulations Plus's current market cap is $640M |
| What is the current revenue of Simulations Plus? | Simulations Plus's last 12 months revenue is $85.2M. |
| What is the current revenue growth of Simulations Plus? | Simulations Plus revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Simulations Plus? | Current revenue multiple of Simulations Plus is 7.3x. |
| Is Simulations Plus profitable? | Yes, Simulations Plus is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Simulations Plus? | Simulations Plus's last 12 months EBITDA is $26.7M. |
| What is Simulations Plus's EBITDA margin? | Simulations Plus's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of Simulations Plus? | Current EBITDA multiple of Simulations Plus is 23.2x. |
| What is the current FCF of Simulations Plus? | Simulations Plus's last 12 months FCF is $9.6M. |
| What is Simulations Plus's FCF margin? | Simulations Plus's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Simulations Plus? | Current FCF multiple of Simulations Plus is 64.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
